Adagene to Present at Investor Conferences in June
Adagene to Present at Investor Conferences in June
SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.
2024年5月22日，美国圣迭戈和中国苏州（环球新闻线） - Adagene， Inc.（“Adagene”）（纳斯达克：ADAG）是一家转化创新抗体治疗药物的发现与开发公司，今天宣布将参加2024年6月的多个投资者会议。
Adagene's Chairman, Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will provide a company update, including progress on the masked, anti-CTLA-4 SAFEbody ADG126. Company management will also host investor meetings.
Adagene的董事长、首席执行官和研发总裁彼得·罗博士将提供公司更新，包括抗CTLA-4掩蔽型SAFEbody ADG126的进展情况。公司管理层还将举办投资者会议。
Jefferies Global Healthcare Conference 2024
Jefferies全球医疗保健会议2024
Date: Wednesday, June 5
Time: 4:30-4:55 PM (Eastern Time)
Location: New York City
日期：6月5日星期三
时间：美国东部时间下午4:30-4:55
地点：纽约市
Goldman Sachs 45th Annual Global Healthcare Conference
高盛第45届全球医疗保健大会
Date: Thursday, June 13
Time: 10:00-10:35 AM (Eastern Time)
Location: Miami
日期：6月13日星期四
时间：美国东部时间上午10:00-10:35
地点：迈阿密
HC Wainwright 2nd Annual Immune Cell Engager Virtual Conference
HC Wainwright第二届免疫细胞诱导剂虚拟会议
Date: Tuesday, June 25
Time: TBD for presentation
Location: Virtual
日期：6月25日星期二
时间：待定
地点：虚拟
A live webcast of the presentations will also be accessible in the Investors section of the company's website. A webcast replay will be available for at least 30 days.
公司网站的投资者部分将提供演示文稿的实时网络直播。回放将在网站上至少提供30天。